Copyright Reports & Markets. All rights reserved.

Global Choroidal Neovascularization Market Research Report 2019

Request for Sample of this report
Buy now

Table of Contents

    Executive Summary

      1 Choroidal Neovascularization Market Overview

      • 1.1 Product Overview and Scope of Choroidal Neovascularization
      • 1.2 Choroidal Neovascularization Segment by Type
        • 1.2.1 Global Choroidal Neovascularization Production Growth Rate Comparison by Type (2014-2025)
        • 1.2.2 Intravenous
        • 1.2.3 Intravitreal
      • 1.3 Choroidal Neovascularization Segment by Application
        • 1.3.1 Choroidal Neovascularization Consumption Comparison by Application (2014-2025)
        • 1.3.2 Extreme Myopia
        • 1.3.3 Malignant Myopic Degeneration
        • 1.3.4 Age-Related Developments
      • 1.4 Global Choroidal Neovascularization Market by Region
        • 1.4.1 Global Choroidal Neovascularization Market Size Region
        • 1.4.2 North America Status and Prospect (2014-2025)
        • 1.4.3 Europe Status and Prospect (2014-2025)
        • 1.4.4 China Status and Prospect (2014-2025)
        • 1.4.5 Japan Status and Prospect (2014-2025)
      • 1.5 Global Choroidal Neovascularization Market Size
        • 1.5.1 Global Choroidal Neovascularization Revenue (2014-2025)
        • 1.5.2 Global Choroidal Neovascularization Production (2014-2025)

      2 Global Choroidal Neovascularization Market Competition by Manufacturers

      • 2.1 Global Choroidal Neovascularization Production Market Share by Manufacturers (2014-2019)
      • 2.2 Global Choroidal Neovascularization Revenue Share by Manufacturers (2014-2019)
      • 2.3 Global Choroidal Neovascularization Average Price by Manufacturers (2014-2019)
      • 2.4 Manufacturers Choroidal Neovascularization Production Sites, Area Served, Product Types
      • 2.5 Choroidal Neovascularization Market Competitive Situation and Trends
        • 2.5.1 Choroidal Neovascularization Market Concentration Rate
        • 2.5.2 Choroidal Neovascularization Market Share of Top 3 and Top 5 Manufacturers
        • 2.5.3 Mergers & Acquisitions, Expansion

      3 Global Choroidal Neovascularization Production Market Share by Regions

      • 3.1 Global Choroidal Neovascularization Production Market Share by Regions
      • 3.2 Global Choroidal Neovascularization Revenue Market Share by Regions (2014-2019)
      • 3.3 Global Choroidal Neovascularization Production, Revenue, Price and Gross Margin (2014-2019)
      • 3.4 North America Choroidal Neovascularization Production
        • 3.4.1 North America Choroidal Neovascularization Production Growth Rate (2014-2019)
        • 3.4.2 North America Choroidal Neovascularization Production, Revenue, Price and Gross Margin (2014-2019)
      • 3.5 Europe Choroidal Neovascularization Production
        • 3.5.1 Europe Choroidal Neovascularization Production Growth Rate (2014-2019)
        • 3.5.2 Europe Choroidal Neovascularization Production, Revenue, Price and Gross Margin (2014-2019)
      • 3.6 China Choroidal Neovascularization Production (2014-2019)
        • 3.6.1 China Choroidal Neovascularization Production Growth Rate (2014-2019)
        • 3.6.2 China Choroidal Neovascularization Production, Revenue, Price and Gross Margin (2014-2019)
      • 3.7 Japan Choroidal Neovascularization Production (2014-2019)
        • 3.7.1 Japan Choroidal Neovascularization Production Growth Rate (2014-2019)
        • 3.7.2 Japan Choroidal Neovascularization Production, Revenue, Price and Gross Margin (2014-2019)

      4 Global Choroidal Neovascularization Consumption by Regions

      • 4.1 Global Choroidal Neovascularization Consumption by Regions
      • 4.2 North America Choroidal Neovascularization Consumption (2014-2019)
      • 4.3 Europe Choroidal Neovascularization Consumption (2014-2019)
      • 4.4 China Choroidal Neovascularization Consumption (2014-2019)
      • 4.5 Japan Choroidal Neovascularization Consumption (2014-2019)

      5 Global Choroidal Neovascularization Production, Revenue, Price Trend by Type

      • 5.1 Global Choroidal Neovascularization Production Market Share by Type (2014-2019)
      • 5.2 Global Choroidal Neovascularization Revenue Market Share by Type (2014-2019)
      • 5.3 Global Choroidal Neovascularization Price by Type (2014-2019)
      • 5.4 Global Choroidal Neovascularization Production Growth by Type (2014-2019)

      6 Global Choroidal Neovascularization Market Analysis by Applications

      • 6.1 Global Choroidal Neovascularization Consumption Market Share by Application (2014-2019)
      • 6.2 Global Choroidal Neovascularization Consumption Growth Rate by Application (2014-2019)

      7 Company Profiles and Key Figures in Choroidal Neovascularization Business

      • 7.1 Pfizer Inc.
        • 7.1.1 Pfizer Inc. Choroidal Neovascularization Production Sites and Area Served
        • 7.1.2 Choroidal Neovascularization Product Introduction, Application and Specification
        • 7.1.3 Pfizer Inc. Choroidal Neovascularization Production, Revenue, Price and Gross Margin (2014-2019)
        • 7.1.4 Main Business and Markets Served
      • 7.2 F. Hoffmann-La Roche Ltd.
        • 7.2.1 F. Hoffmann-La Roche Ltd. Choroidal Neovascularization Production Sites and Area Served
        • 7.2.2 Choroidal Neovascularization Product Introduction, Application and Specification
        • 7.2.3 F. Hoffmann-La Roche Ltd. Choroidal Neovascularization Production, Revenue, Price and Gross Margin (2014-2019)
        • 7.2.4 Main Business and Markets Served
      • 7.3 Novartis AG
        • 7.3.1 Novartis AG Choroidal Neovascularization Production Sites and Area Served
        • 7.3.2 Choroidal Neovascularization Product Introduction, Application and Specification
        • 7.3.3 Novartis AG Choroidal Neovascularization Production, Revenue, Price and Gross Margin (2014-2019)
        • 7.3.4 Main Business and Markets Served
      • 7.4 Regeneron Pharmaceuticals Inc.
        • 7.4.1 Regeneron Pharmaceuticals Inc. Choroidal Neovascularization Production Sites and Area Served
        • 7.4.2 Choroidal Neovascularization Product Introduction, Application and Specification
        • 7.4.3 Regeneron Pharmaceuticals Inc. Choroidal Neovascularization Production, Revenue, Price and Gross Margin (2014-2019)
        • 7.4.4 Main Business and Markets Served
      • 7.5 Bayer AG
        • 7.5.1 Bayer AG Choroidal Neovascularization Production Sites and Area Served
        • 7.5.2 Choroidal Neovascularization Product Introduction, Application and Specification
        • 7.5.3 Bayer AG Choroidal Neovascularization Production, Revenue, Price and Gross Margin (2014-2019)
        • 7.5.4 Main Business and Markets Served
      • 7.6 QLT Inc.
        • 7.6.1 QLT Inc. Choroidal Neovascularization Production Sites and Area Served
        • 7.6.2 Choroidal Neovascularization Product Introduction, Application and Specification
        • 7.6.3 QLT Inc. Choroidal Neovascularization Production, Revenue, Price and Gross Margin (2014-2019)
        • 7.6.4 Main Business and Markets Served
      • 7.7 Sanwa Kagaku Kenkyusho Co. Ltd.
        • 7.7.1 Sanwa Kagaku Kenkyusho Co. Ltd. Choroidal Neovascularization Production Sites and Area Served
        • 7.7.2 Choroidal Neovascularization Product Introduction, Application and Specification
        • 7.7.3 Sanwa Kagaku Kenkyusho Co. Ltd. Choroidal Neovascularization Production, Revenue, Price and Gross Margin (2014-2019)
        • 7.7.4 Main Business and Markets Served
      • 7.8 Promedior Inc.
        • 7.8.1 Promedior Inc. Choroidal Neovascularization Production Sites and Area Served
        • 7.8.2 Choroidal Neovascularization Product Introduction, Application and Specification
        • 7.8.3 Promedior Inc. Choroidal Neovascularization Production, Revenue, Price and Gross Margin (2014-2019)
        • 7.8.4 Main Business and Markets Served
      • 7.9 Valeant Pharmaceuticals International Inc.
        • 7.9.1 Valeant Pharmaceuticals International Inc. Choroidal Neovascularization Production Sites and Area Served
        • 7.9.2 Choroidal Neovascularization Product Introduction, Application and Specification
        • 7.9.3 Valeant Pharmaceuticals International Inc. Choroidal Neovascularization Production, Revenue, Price and Gross Margin (2014-2019)
        • 7.9.4 Main Business and Markets Served
      • 7.10 Gilead Sciences Inc
        • 7.10.1 Gilead Sciences Inc Choroidal Neovascularization Production Sites and Area Served
        • 7.10.2 Choroidal Neovascularization Product Introduction, Application and Specification
        • 7.10.3 Gilead Sciences Inc Choroidal Neovascularization Production, Revenue, Price and Gross Margin (2014-2019)
        • 7.10.4 Main Business and Markets Served

      8 Choroidal Neovascularization Manufacturing Cost Analysis

      • 8.1 Choroidal Neovascularization Key Raw Materials Analysis
        • 8.1.1 Key Raw Materials
        • 8.1.2 Price Trend of Key Raw Materials
        • 8.1.3 Key Suppliers of Raw Materials
      • 8.2 Proportion of Manufacturing Cost Structure
      • 8.3 Manufacturing Process Analysis of Choroidal Neovascularization
      • 8.4 Choroidal Neovascularization Industrial Chain Analysis

      9 Marketing Channel, Distributors and Customers

      • 9.1 Marketing Channel
        • 9.1.1 Direct Marketing
        • 9.1.2 Indirect Marketing
      • 9.2 Choroidal Neovascularization Distributors List
      • 9.3 Choroidal Neovascularization Customers

      10 Market Dynamics

      • 10.1 Market Trends
      • 10.2 Opportunities
      • 10.3 Market Drivers
      • 10.4 Challenges
      • 10.5 Influence Factors

      11 Global Choroidal Neovascularization Market Forecast

      • 11.1 Global Choroidal Neovascularization Production, Revenue Forecast
        • 11.1.1 Global Choroidal Neovascularization Production Growth Rate Forecast (2019-2025)
        • 11.1.2 Global Choroidal Neovascularization Revenue and Growth Rate Forecast (2019-2025)
        • 11.1.3 Global Choroidal Neovascularization Price and Trend Forecast (2019-2025)
      • 11.2 Global Choroidal Neovascularization Production Forecast by Regions (2019-2025)
        • 11.2.1 North America Choroidal Neovascularization Production, Revenue Forecast (2019-2025)
        • 11.2.2 Europe Choroidal Neovascularization Production, Revenue Forecast (2019-2025)
        • 11.2.3 China Choroidal Neovascularization Production, Revenue Forecast (2019-2025)
        • 11.2.4 Japan Choroidal Neovascularization Production, Revenue Forecast (2019-2025)
      • 11.3 Global Choroidal Neovascularization Consumption Forecast by Regions (2019-2025)
        • 11.3.1 North America Choroidal Neovascularization Consumption Forecast (2019-2025)
        • 11.3.2 Europe Choroidal Neovascularization Consumption Forecast (2019-2025)
        • 11.3.3 China Choroidal Neovascularization Consumption Forecast (2019-2025)
        • 11.3.4 Japan Choroidal Neovascularization Consumption Forecast (2019-2025)
      • 11.4 Global Choroidal Neovascularization Production, Revenue and Price Forecast by Type (2019-2025)
      • 11.5 Global Choroidal Neovascularization Consumption Forecast by Application (2019-2025)

      12 Research Findings and Conclusion

        13 Methodology and Data Source

        • 13.1 Methodology/Research Approach
          • 13.1.1 Research Programs/Design
          • 13.1.2 Market Size Estimation
          • 13.1.3 Market Breakdown and Data Triangulation
        • 13.2 Data Source
          • 13.2.1 Secondary Sources
          • 13.2.2 Primary Sources
        • 13.3 Author List

        Choroidal neovascularization describes the growth of new blood vessels that originate from the choroid through a break in the Bruch membrane into the sub–retinal pigment epithelium (sub-RPE) or subretinal space.

        The global Choroidal Neovascularization market is valued at xx million US$ in 2018 is expected to reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2019-2025.
        This report focuses on Choroidal Neovascularization volume and value at global level, regional level and company level. From a global perspective, this report represents overall Choroidal Neovascularization market size by analyzing historical data and future prospect. Regionally, this report focuses on several key regions: North America, Europe, China and Japan.
        At company level, this report focuses on the production capacity, ex-factory price, revenue and market share for each manufacturer covered in this report.

        The following manufacturers are covered:
        Pfizer Inc.
        F. Hoffmann-La Roche Ltd.
        Novartis AG
        Regeneron Pharmaceuticals Inc.
        Bayer AG
        QLT Inc.
        Sanwa Kagaku Kenkyusho Co. Ltd.
        Promedior Inc.
        Valeant Pharmaceuticals International Inc.
        Gilead Sciences Inc

        Segment by Regions
        North America
        Europe
        China
        Japan

        Segment by Type
        Intravenous
        Intravitreal

        Segment by Application
        Extreme Myopia
        Malignant Myopic Degeneration
        Age-Related Developments

        Buy now